LIGAND PHARMACEUTICALS INC
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| 4 | PRIMARY DOCUMENT | Mar 27, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 27, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 27, 2026 |
| SCHEDULE 13G/A | — | Mar 27, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 25, 2026 |
| 144 | — | Mar 23, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 13, 2026 |
| 144 | — | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 6, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 6, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Espinoza Octavio | Chief Financial Officer | Sale | 1,804 @ $188.31 | 26,186 | Dec 12, 2025 |
| KOZARICH JOHN W | — | Sale | 92 @ $197.72 | 44,174 | Dec 1, 2025 |
| KOZARICH JOHN W | — | Sale | 49 @ $190.26 | 44,922 | Nov 3, 2025 |
| KOZARICH JOHN W | — | Sale | 24 @ $177.60 | 45,498 | Oct 1, 2025 |
| Aryeh Jason | — | Sale | 4,628 @ $170.96 | 70,243 | Sep 23, 2025 |
| KOZARICH JOHN W | — | Sale | 85 @ $164.25 | 45,522 | Sep 2, 2025 |
| KOZARICH JOHN W | — | Sale | 467 @ $131.88 | 45,989 | Aug 1, 2025 |
| KOZARICH JOHN W | — | Sale | 934 @ $125.00 | 46,456 | Jul 10, 2025 |
| Reardon Andrew | CLO & Secretary | Sale | 500 @ $114.08 | 31,903 | Jun 23, 2025 |
| Reardon Andrew | CLO & Secretary | Sale | 500 @ $114.54 | 32,403 | Jun 10, 2025 |